Tag: Cognos Therapeutics

[ad_1] WILMINGTON, Del. and INGLEWOOD, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Nocturne Acquisition Corporation (NASDAQ:MBTC, MBTCU, MBTCR) (“Nocturne”) and Cognos Therapeutics, Inc. (“Cognos”) today announced the engagement of Chardan,…